[HPV-infection].
Cervical carcinoma is worldwide the third most frequent carcinoma affecting women; regionally, it is sometimes even the most frequent form of female cancer. Moreover, anogenital dysplasia and genital warts represent a major health care problem. With the development of bivalent and quadrivalent prophylactic vaccines against HPV 16 and 18 or HPV 6, 11, 16 and 18, respectively, a very promising immunoprophylaxis is now available to prevent the development of HPV-associated diseases and in particular, cervical carcinoma.
Schmidt-Petruschkat
S
S
Fachärztin f. Gynäkologie u. Geburtshilfe Dysplasiesprechstunde, Inst. für Zytologie und Genetik Nordrhein, Virchow-Str. 20, D-46047 Oberhausen. silke.schmidt-petruschkat@gmx.de
D000293:Adolescent; D000328:Adult; D002648:Child; D005194:Family Practice; D005260:Female; D005858:Germany; D006801:Humans; D017589:Immunization Programs / Q000191:economics; D019458:Insurance Coverage / Q000191:economics; D008297:Male; D009313:National Health Programs / Q000191:economics; D030361:Papillomavirus Infections / Q000175:diagnosis / Q000517:prevention & control* / Q000635:transmission; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D010353:Patient Education as Topic; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D014626:Vaginal Smears / Q000191:economics
D053918:Papillomavirus Vaccines